Reframing small cell lung cancer: therapeutic lessons from hematologic malignancies
Kanak Parmar, Ira Surolia, Anish Thomas · 2026
Read Reframing small cell lung cancer: therapeutic lessons from hematologic malignancies by Kanak Parmar, Ira Surolia, Anish Thomas (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13171363.txt.
Description
Kanak Parmar, Ira Surolia, and Anish Thomas argue, in a 2026 review, that a fierce lung cancer can be understood through the lens of blood cancers. Small cell lung cancer grows fast, spreads early, and rarely yields long survival, though it first responds well to therapy. It shares traits with hematologic malignancies: its cells switch states, evade treatment by changing form, and may be hit by immune therapies aimed at surface markers.
Those switches are driven by epigenetic and transcriptional reprogramming, not new mutations. They steer which markers the tumor shows and how vulnerable it is to treatment. New tools that link immune cells to tumor markers show promise, capped by mixed markers, shifting states, and a cold immune environment. Drugs that alter gene marks may reset the state and open the tumor to attack. The authors back timed combinations that box in the tumor's shape shifts.
Catalog record
| CREATOR | Kanak Parmar, Ira Surolia, Anish Thomas |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |